Drug
Betablocker
Betablocker is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_4
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting1
unknown1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
recruiting133%
unknown133%
active_not_recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_4
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
NCT03646357
recruitingnot_applicable
Ivabradine in Cirrhotic Cardiomyopathy
NCT04111133
unknown
The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction
NCT04564365
Clinical Trials (3)
Showing 3 of 3 trials
NCT03646357Phase 4
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
NCT04111133Not Applicable
Ivabradine in Cirrhotic Cardiomyopathy
NCT04564365
The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3